US FDA approves Meda's once-daily nasal antihistamine Astepro
   
 
Home | Support
 
Headline News:
FDA
Fake Drugs
Drug Testing
Internet Safety
 
 
US FDA approves Meda's once-daily nasal antihistamine Astepro
5 Sep 09, 09:51
The US Food and Drug Administration (FDA) approved Astepro (azelastine) nasal spray 0.15% for the treatment of the symptoms of seasonal and perennial allergic rhinitis.
more

 

 
© 2007 nafdacnigeria.org